Renee Rhem, PA
Medical · New York, NYNPI 1346509239
Payments from drug & device makers
Across 554 payments — averaging $27.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$3K
- Sanofi$3K
- AstraZeneca$2K
- CSL Behring$1K
- AbbVie$804
- Regeneron Healthcare Solutions, Inc.$803
- plus $5K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 118 | $2,842 |
| Sanofi | 56 | $2,563 |
| AstraZeneca | 40 | $2,049 |
| CSL Behring | 50 | $1,165 |
| AbbVie | 21 | $804 |
| Regeneron Healthcare Solutions, Inc. | 24 | $803 |
| Biocryst US Sales Co., LLC | 73 | $747 |
| Novartis | 24 | $499 |
| Teva Pharmaceuticals USA, Inc. | 18 | $419 |
| Kaleo, Inc. | 14 | $372 |
| Incyte Corporation | 22 | $368 |
| Amgen | 11 | $333 |
| Galderma Laboratories, L.p. | 10 | $294 |
| Blueprint Medicines Corporation | 8 | $277 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $237 |
| Lilly USA, LLC | 5 | $180 |
| Pfizer | 7 | $154 |
| Grifols USA, LLC | 8 | $148 |
| Ionis Pharmaceuticals, Inc. | 12 | $139 |
| Organon | 2 | $137 |
| Convatec Inc. | 1 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $134 |
| Sanofi-aventis U.S. LLC | 2 | $116 |
| Optinose US, Inc. | 3 | $51 |
| Genentech USA, Inc. | 3 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $25 |
| Mylan Specialty L.p. | 1 | $24 |
| Alk-abello, Inc | 1 | $21 |
| Pharming Healthcare, Inc. | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
How this compares
$15,132 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in New York
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Maureen ThyneNew York$109K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
- Maria BaldoNew York$40K
- Michael QuerijeroNew York$32K
- Meiting LiangNew York$25K
- Karina SodenNew York$23K
- Valentin BonillaNew York$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.